Role of Reactivating Mutant p53 Protein in Suppressing Growth and Metastasis of Triple-Negative Breast Cancer.

Publication Year: 2022

DOI:
10.2147/OTT.S342292

PMCID:
PMC8754468

PMID:
35035222

Journal Information

Full Title: Onco Targets Ther

Abbreviation: Onco Targets Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors report no conflicts of interest in this work."

Evidence found in paper:

"We would like to thank the many students and technicians involved in the studies reported from the Hyder laboratory. Dr. Yayun Liang deserves special recognition for her expertise and for participation in many experiments in our laboratory. Studies related to p53 were supported by grants from the National Institutes of Health and the Department of Defense, as well as awards from the College of Veterinary Medicine at the University of Missouri. Taylor Berke is an Honors student at MU and a Cherng Scholar in the School of Biological Sciences at the University of Missouri-Columbia. SMH is the Zalk Missouri Professor of Tumor Angiogenesis."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025